‘Mini-win' for Canada as digital services tax dropped, expert says
Former special advisor to the Ministry of Finance Julian Karaguesian on if dropping the digital service tax gives Canada additional leverage during trade talks.
Days after Ottawa rescinded the digital services tax aimed at tech companies to advance trade negotiations with the U.S., critics have voiced their disappointment in the government's handling of the situation.
But one expert calls this move by Prime Minister Mark Carney a 'mini-win.'
The play made by the federal government to hold on to the tax until the last minute before giving in made it appear as though a concession had been made, Julian Karaguesian, an economist and former special advisor at the Ministry of Finance, told CTV News Channel on Tuesday.
'We also had to back down publicly and double down on this tax,' Karaguesian said. 'But I think that was a good strategic, tactical manoeuvre by the Prime Minister.'
The feds dropped the tax hours before the first payment was due, three days after U.S. President Donald Trump suspended trade talks over it.
Carney called it 'part of a bigger negotiation.'
'No sovereignty over domestic policy'
According to Karaguesian, Canada is facing significant pressures and challenges on federal and provincial budgets, in addition to the pressure of boosting defence spending to 5 per cent of GDP in the coming decade.
'There's a sovereignty issue. The digital services tax is a domestic policy,' Karaguesian points out.
'What we're seeing from the White House is they're telling their allies that 'you have no sovereignty over your domestic policy. We will use leverage in terms of access to our market to cancel any policy that we believe interferes with our business interests.''
'Truly internal economy'
Meanwhile, the removal of provincial trade barriers is largely symbolic when it comes to direct barriers, Karaguesian explains.
If all provinces and territories eliminated the most egregious interprovincial trade barriers, the federal government could promote policies to boost Canada's economy and productivity, creating what Karaguesian calls a 'truly internal economy.'
However, despite progress on removing these trade barriers, there is a certain risk associated with different jurisdictions taking different approaches, a recent report by the Canadian Federation of Independent Business said.
'A natural resource superpower'
Karaguesian says Canada needs to reduce its trade dependence on the U.S. and consider expanding trade with countries like India, China, and Europe.
He highlights the importance of focusing on Canada's infrastructure — especially transportation and telecommunications.
'We are a natural resource superpower,' Karaguesian said.
'We were a rich country before we had total free trade with the U.S., and we will stay a rich country if we make good choices. We just have to reduce our dependence on a single trading partner, which is (not) treating us as a partner and an ally but rather using our economic interdependence as a weapon to squeeze concessions out of us.'
The 30-day trade deal deadline announced after Carney and Trump met in Alberta during the G7 summit will come to an end on July 21.
Canada is expected to adjust counter-tariffs on steel and aluminium products to 'consistent' levels in conjunction with the trade talks held with the U.S., Carney said two weeks ago.
With files from CTV News' Luca Caruso-Moro and the Canadian Press
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
9 minutes ago
- Globe and Mail
Will AbbVie's Acquisition Spree Aid Pipeline Growth?
AbbVie ABBV has been actively ramping up its deal-making efforts lately, thereby strengthening its pipeline. While immunology remains its core area, the company is also signing some early-stage deals across various other therapeutic areas, including oncology and neuroscience. Earlier this week, AbbVie signed a definitive agreement to acquire privately held biotech Capstan Therapeutics for a total deal value of nearly $2.1 billion. The transaction, expected to be completed in the third quarter, will add Capstan's lead asset, CPTX2309 — a potential first-in-class in vivo tLNP anti-CD19 CAR-T therapy — to its immunology pipeline. The acquisition will also add Capstan's proprietary tLNP platform technology, CellSeeker, which helps deliver RNA, like mRNA, to engineer specific cell types inside the body. Since the beginning of last year, the company has signed over 20 early-stage deals, including promising technologies and innovative mechanisms that can elevate the standard of care across various therapeutic areas. Earlier this year, AbbVie acquired rights to develop a long-acting amylin analog for the treatment of obesity from Denmark's Gubra, marking its foray into the obesity space. It also plans to invest further in obesity. Among some recent larger deals, AbbVie acquired ImmunoGen, which added the ovarian cancer drug Elahere and neuroscience drugmaker Cerevel Therapeutics last year. These acquisitions have not only broadened AbbVie's therapeutic footprint but also diversified its pipeline across multiple modalities. The augmented pipeline now includes next-generation immunology candidates, bispecifics, antibody-drug conjugates and innovative therapies for neuropsychiatric and neurodegenerative disorders. We believe ABBV will continue pursuing such deals to further grow its pipeline. Focus on M&A in 2025 While broader macroeconomic concerns, including Trump-era tariffs and leadership shifts at the FDA, have weighed on deal-making this year, Big Pharma continues to pursue strategic assets in key growth areas. Last month, Eli Lilly LLY announced its intent to acquire cardiology-focused Verve Therapeutics in a deal valued at up to $1.3 billion. This transaction, which is also expected to close in the third quarter, will mark LLY's third targeted M&A deal this year. Earlier in January, it signed a $2.5 billion deal for Scorpion Therapeutics' experimental oncology drug. In May, Lilly agreed to acquire SiteOne Therapeutics for $1 billion to strengthen its neuroscience pipeline. Such deals suggest that LLY's M&A strategy is selective, focusing on long-term strength across therapeutic areas beyond its dominant presence in obesity. In June, Sanofi SNY announced a $9.5 billion acquisition of Blueprint Medicines to strengthen its immunology pipeline and reduce reliance on the blockbuster drug Dupixent. Through this transaction, SNY intends to add Ayvakit — an inhibitor of KIT and PDGFRA proteins with growing commercial traction — and several early-stage pipeline assets focused on systemic mastocytosis (SM). Recently, Sanofi completed the acquisition of an investigational bispecific antibody targeting autoimmune diseases from California-based Dren Bio and also agreed to acquire neurology-focused Vigil Neuroscience in a deal valued at around $470 million. ABBV's Price Performance, Valuation and Estimates Shares of AbbVie have outperformed the industry year to date, as seen in the chart below. From a valuation standpoint, AbbVie is not very cheap. Based on the price/earnings (P/E) ratio, the company's shares currently trade at 14.42 times forward earnings, slightly lower than its industry's average of 14.86. The stock is cheaper than some other large drugmakers, such as Eli Lilly and Novo Nordisk, but priced much higher than most other large drugmakers. The stock is also trading above its five-year mean of 12.46. The Zacks Consensus Estimate for 2025 EPS has risen from $12.26 to $12.28, while that for 2026 has remained consistent at $14.06 over the past 60 days. AbbVie currently has a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Sanofi (SNY): Free Stock Analysis Report Eli Lilly and Company (LLY): Free Stock Analysis Report AbbVie Inc. (ABBV): Free Stock Analysis Report This article originally published on Zacks Investment Research (
Globe and Mail
14 minutes ago
- Globe and Mail
Belgravia Hartford Increases Bitcoin (BTC) Treasury Holdings with USD $1 Million Strategic Purchase
Toronto, Ontario--(Newsfile Corp. - July 2, 2025) - Belgravia Hartford Capital Inc. (CSE: BLGV) (OTC Pink: BLGVF) (FSE: ECA) ("Belgravia" or the "Company") is pleased to announce the successful completion of its fourth Bitcoin (BTC) acquisition as part of its long-term Bitcoin Treasury Reserve strategy. This latest purchase further strengthens Belgravia's position as a forward-thinking public company leveraging Bitcoin as a strategic treasury asset. New Bitcoin Acquisition Belgravia Hartford acquired 9.35295508 BTC for a total consideration of USD $1,000,000, executed at an average price of $106,918.08 per Bitcoin (inclusive of all costs and fees). This purchase increases the Company's cumulative Bitcoin holdings to: All figures in USD. The purchase was facilitated through Coinsquare's regulated OTC desk and funded by the previously announced USD $5 million credit facility provided by Round13 Digital Asset Fund L.P.; a premier institutional partner focused on digital asset strategies. Commitment to Transparency and Governance Belgravia Hartford remains committed to full transparency in its treasury operations and will continue to provide timely updates on all material developments. Insiders of the Company currently hold approximately 36% of the outstanding shares, underscoring strong internal alignment with shareholders. Up-to-date insider disclosures are available at ******************************* For legal disclaimers and further corporate information, please visit:
Globe and Mail
15 minutes ago
- Globe and Mail
Competition Bureau issues warning on rental price fixing
Canada's federal competition watchdog has sent a warning on price collusion to landlords and property managers, provoking both condemnation and questions about how price-fixing might arise. 'The Competition Bureau is aware that some landlords and property managers may be engaging with their competitors, including through discussion groups on social media. While some discussions between competitors may be justified, others could be illegal,' warned the bulletin from the Competition Bureau of Canada issued on June 25. It noted that some agreements to fix prices are criminal offences with the potential for prison sentences. While the agency doesn't comment on the specifics of investigations, it was able to share that tips and other information it has received make it clear that potentially illegal conspiring is happening on online messaging services such as WhatsApp, Signal and Snapchat. 'These are very private groups of people, that's the modus operandi. If there are very secretive price-fixing agreements, these actors try to mask their dealings,' said Pierre-Yves Guay, deputy commissioner of the cartels directorate for the Bureau. 'I can tell you we are looking very seriously into certain markets in Canada. The warning is to make sure people understand this is high risk. Eventually, we will detect it.' Mr. Guay couldn't recall a time when the Bureau has filed criminal charges over a rental pricing scheme, though it has brought cases and prosecutions in the real estate space around everything from digital services access by The Toronto Regional Real Estate Board to price-fixing among condominium renovation companies. Growing number of renters are waiting for home prices to decline further before buying, report says Some in the industry said they found the warning baffling, saying they've never seen attempts to illegally fix rental prices. 'We don't participate in any industry pricing discussions or forums, and frankly, we have no need to,' said Nathan Levinson, founder and chief executive officer of Royal York Property Management, which manages more than 25,000 rental units in the Toronto region and beyond. He said that his company provides pricing data to clients, who set the asking rents themselves. 'What we do provide is powerful proprietary software and data tools: These tools help pull all the data from MLS listings, internal rental history, and thousands of private listings not publicly available. These tools allow landlords to make smart pricing decisions based on real-time market evidence, so they don't overprice and sit vacant, or underprice and leave money on the table.' Data tools that use artificially intelligence algorithms to compare private rental data from competitors to build pricing models for clients have become a source of anti-competitive prosecutions in the United States. Mr. Guay said Canada's regulators are closely monitoring the U.S. Department of Justice's case against RealPage Inc. and several landlord co-defendants. Smelling a bargain, investors look to bulk-buy leftover GTA condos In Canada, tenant advocates say they haven't seen much of the kind of price-fixing chat room collusion the Bureau referenced, but online forums of small landlords sharing industry tips is all too familiar. 'During COVID – during the eviction moratorium and rent freezes – we started hearing from tenants and other clinics about landlords going onto these chats about how to break the law and circumvent the law, for example illegally locking tenants out,' said Dania Majid, staff lawyer for Advocacy Centre for Tenants Ontario (ACTO) and director of its tenant duty counsel program that provides free legal advice to tenants at Ontario's Landlord Tenant Board. 'It doesn't surprise us. We know investors have conversations among one another: Landlords counselling how to charge illegal fees – cleaning fees and security fees, and others not contemplated under the Act – this type of bad advice is a type of collusion.' Many in the industry believe price-fixing is most likely to take root or be most effective outside of the biggest cities with the most rental stock. 'I think in the Canadian context this applies much more to the landlords and property managers of high-rise buildings especially outside of large urban centres' where they hold a greater share of the rental market units in a given area. said Brandon Sage, real estate investment adviser at LandLord Property & Rental Management Inc. 'In Toronto, most rentals … hundreds of thousands of condos and multiplexes … [are] owned by almost as many landlords.' Mr. Guay concurred: 'If you have landlords or property managers that have a lot of market power … the more power you have and the more likely you'll be able to make it stick,' he said. This engaged expat couple seeks a starter home in Toronto under $950,000 – with room to grow While the general rental picture across Canada has been one of falling rental rates, there are places that perform above expectations. According to asking rents in Toronto for one-bedroom apartments fell 0.7 per cent from April to May, but were down 7 per cent year over year; two-bedroom units bumped up a bit in May (0.3 per cent) but were down by 10.7 per cent from the same period in 2024. Meanwhile, in nearby Ajax, Ont., asking rents saw robust growth in the same period with one-bedrooms rising 3.4 per cent month over month and leaping up 7.8 per cent year over year. 'From a Toronto lens, it is hard to believe that there are enough willing participants with enough units to truly have an impact on the market,' said Ben Myers, president of Bullpen Research and Consulting Inc. 'Rental developers face immense competition from the 'shadow' inventory of rental supply, hundreds of thousands of individual investors, which would be very difficult to imagine them collectively colluding on anything.' Another factor that could inhibit the ability of landlords attempting to collude on a rent-fixing scheme are the other participants in the transaction: the tenants. 'Tenants are very well educated; there's so much information and resources for them. From what I've seen if you're not competitively priced, tenants are so good at jumping to the building next door,' said Sabine Ghali, managing director of Buttonwood Property Management.
